Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase

Acta Poloniae Pharmaceutica - Drug Research

Volumn 63, Issue 6, 2006, Pages 471-476

  Stanisz, Beata ^a   Kania, Łukasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Atorvastatin (ATO); HPLC method; Oxazepam (IS); Stability

Indexed keywords

ACETONITRILE; ATORVASTATIN; PHOSPHORIC ACID; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ARTICLE; CORRELATION COEFFICIENT; DEGRADATION KINETICS; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG STABILITY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; TABLET FORMULATION; VALIDATION PROCESS; CHEMISTRY; METHODOLOGY; SENSITIVITY AND SPECIFICITY; TABLET; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HEPTANOIC ACIDS; PYRROLES; SENSITIVITY AND SPECIFICITY; TABLETS;

EID: 34248231958     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Petanceska S., Browne P.: Curr. Alzheimer Res. 2, 343 (2005).
2. Gee M., Hasson N.K., Hahn T., Ryono R.: J. Manag. Care Pharm. 8, 453 (2002).
3. Castano G., Mas R., Fernandez L., Illnait J., Mesa M., Alvarez E., Lezcay M.: Drugs Aging 20, 153 (2003).
4. Zaja̧c M., Pawełczyk E.: Inhibitory hydroksymetyloglutarylokoenzymu A (I-HMG-CoA). In Chemia leków, pp. 401-403, A.M. Poznań, 2000 (in Polish).
5. Hermann M., Cristensen H., Rebsaet J.L.: Anal. Bioanal. Chem. 382, 1242 (2005).
6. Van Pelt C.K., Corso T.N., Schultz G.A., Lowes S., Henion J.: Anal. Chem. 73, 582 (2001).
7. Miao X.S., Metcalfe C.D.: J. Mass Spectrom. 38, 27 (2003).
8. Jemal M., Ouyang Z., Chen B.C., Teitz D.: Rapid Commun. Mass Spectrom. 13, 1003 (1999).
9. Altuntas G.T., Erk N.: J. Liq. Chromatogr. Relat. Technol. 27, 83 (2004).
10. Bullen W.W., Miller R.A., Hayes, R.N.: J. Am. Soc. Mass Spectrom. 10, 55 (1999).
11. Koytchev R., Ozalp Y., Erenmemisoglu A., van der Meer M.J., Alpan R.S.: Arzneimittel-Forschung 54, 573 (2004).
12. Erturk S., Sevinc-Aktas E., Ersoy L., Ficicioglu S.: J. Pharm. Biomed. Anal. 33, 1017 (2003).
13. ICH Steering Committee, in: European Agency for the Evaluation of Medicinal Products, International Commission on Harmonisation, London (CPMP/ICH/381/95), 1994.
14. ICH Steering Committee, ICH Q2B Validation of Analytical Procedures: methodology, European Agency for the Evaluation of Medicinal Products, International Commission on Harmonisation, London (CPMP/ICH/281/ 95), 1996. Available at: http://www.ich.org/.
15. Papadoyannis N.I., Samanidou F.V.: J. Liq. Chromatogr. Relat. Technol. 27, 753 (2004).
16. Validation of Analytical Methods: Methodology ICH Topic Q2B, Pharm Europa., 1996, 8, 108.
17. Huber, L. Good Laboratory Practice and Current Good Manufacturing Practice, p. 152, Hewlett-Packard, Germany 1994.